Kevin Roche Net Worth

The estimated Net Worth of Kevin H Roche is at least $8.37 Milhão dollars as of 1 October 2021. Mr. Roche owns over 25,755 units of Tactile Systems Technology Inc stock worth over $870,898 and over the last 8 years he sold TCMD stock worth over $7,309,318. In addition, he makes $184,975 as Independent Director at Tactile Systems Technology Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Roche TCMD stock SEC Form 4 insiders trading

Kevin has made over 15 trades of the Tactile Systems Technology Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 25,755 units of TCMD stock worth $285,623 on 1 October 2021.

The largest trade he's ever made was selling 30,000 units of Tactile Systems Technology Inc stock on 2 March 2018 worth over $926,100. On average, Kevin trades about 13,131 units every 80 days since 2016. As of 1 October 2021 he still owns at least 66,228 units of Tactile Systems Technology Inc stock.

You can see the complete history of Mr. Roche stock trades at the bottom of the page.

Kevin Roche biography

Kevin H. Roche serves as Independent Director of the Company. Mr. Roche was General Counsel of UnitedHealth Group, a health insurance provider, from 1989 to 1996, at which time he founded and operated as the Chief Executive Officer of the Ingenix division of UnitedHealth Group, where he served until 2001. Following his retirement from UnitedHealth Group, Mr. Roche has spent several years assisting emerging growth companies as an investor, advisor and board member. He also serves as a Senior Advisor for Triple Tree, LLC. He currently serves as a director for several private healthcare companies. During the past five years, Mr. Roche served on the board of directors of Cogentix Medical, Inc.

What is the salary of Kevin Roche?

As the Independent Director of Tactile Systems Technology Inc, the total compensation of Kevin Roche at Tactile Systems Technology Inc is $184,975. There are 11 executives at Tactile Systems Technology Inc getting paid more, with Gerald R. Mattys having the highest compensation of $1,306,465.

How old is Kevin Roche?

Kevin Roche is 69, he's been the Independent Director of Tactile Systems Technology Inc since 2004. There are 2 older and 12 younger executives at Tactile Systems Technology Inc. The oldest executive at Tactile Systems Technology Inc is Peter Soderberg, 73, who is the Independent Chairman of the Board.

What's Kevin Roche's mailing address?

Kevin's mailing address filed with the SEC is 3701 WAYZATA BLVD., SUITE 300, MINNEAPOLIS, MN, 55416.

Insiders trading at Tactile Systems Technology Inc

Over the last 8 years, insiders at Tactile Systems Technology Inc have traded over $215,774,039 worth of Tactile Systems Technology Inc stock and bought 284,300 units worth $3,558,518 . The most active insiders traders include Zubeen Shroff, Partners V Lp Galen Partner..., eJordan Davis. On average, Tactile Systems Technology Inc executives and independent directors trade stock every 11 days with the average trade being worth of $402,508. The most recent stock trade was executed by Sherri Lee Ferstler on 12 August 2024, trading 1,550 units of TCMD stock currently worth $20,259.

What does Tactile Systems Technology Inc do?

tactile medical is one of the fastest growing companies in medical devices. as a leader in treatment options for lymphedema and venous ulcer therapies, tactile medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling . headquartered in minneapolis, minnesota, we advocate for patient access and serve tens of thousands of patients through a direct national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff.

Complete history of Mr. Roche stock trades at Tactile Systems Technology Inc

Tactile Systems Technology Inc executives and stock owners

Tactile Systems Technology Inc executives and other stock owners filed with the SEC include:

• Gerald R. Mattys,
  Consultant
• Bryan Rishe,
  Senior Vice President of Sales
• Brent Moen,
  Chief Financial Officer
• Daniel L. Reuvers,
  Pres, CEO & Director
• Bryan F. Rishe,
  Sr. VP of Sales
• Brent A. Moen,
  Chief Financial Officer
• Eric C. Pauls,
  Sr. VP of Sales
• Kristie T. Burns,
  Sr. VP of Marketing & Clinical Affairs
• Peter Soderberg,
  Independent Chairman of the Board
• Richard Nigon,
  Independent Director
• William Burke,
  Independent Director
• Kevin Roche,
  Independent Director
• Cheryl Pegus,
  Independent Director
• Raymond Huggenberger,
  Independent Director
• Mike Piccinino,
  IR Contact Officer
• Jay Stracke,
  Vice President of Reimbursement and Payer Relations
• Peter Schaubach,
  Chief Information Officer
• Daniel Reuvers,
  President, Chief Executive Officer, Director
• Janelle Strop,
  Chief Human Resource Officer
• Thomas F. O'Donnell Jr., M.D.,
  Chief Medical Officer & Member of Vascular Strategic Advisory Board
• Kristie Burns,
  Sr. VP of Marketing & Clinical Affairs
• Jerry Sauber,
  VP of Operations
• Eric Pauls,
  Sr. VP of Sales
• Darren J. Wennen,
  Sr. VP of Commercial Operations
• Thomas F. O'Donnell Jr.,
  Chief Medical Officer
• Juleen F. Krings,
  Chief HR Officer
• Sunday J. Hoy,
  VP & Compliance Officer
• Mark W. Aldridge,
  VP of Operations
• Valerie L. Asbury,
  Director
• Robert J. Folkes,
  Chief Operating Officer
• Zubeen Shroff,
  Director
• Mary E. Anderson,
  Vice President, Reimbursement
• Venture Partners Iii, Llcra...,
  
• Jordan Davis,
  Director
• Partners V Lp Galen Partner...,
  
• Lynn Larson Blake,
  Chief Financial Officer
• Gerald R. Mattys,
  Chief Executive Officer
• Stephen I Shapiro,
  Director
• Venture Partners Iii, Llcra...,
  
• Maggie Thompson,
  VP Payer Rltns & Govt Affr
• Deepti Jain,
  Director
• Boyd Vindell Washington,
  Director
• Kristie Burns,
  Sr. VP Mktg & Clinical Affairs
• Eric Pauls,
  Senior VP, Sales
• David Brent Shafer,
  Director
• Carmen B Volkart,
  Director
• Elaine M. Birkemeyer,
  Chief Financial Officer
• Sherri Lee Ferstler,
  Senior VP, Sales
• Sheri Louise Dodd,
  Chief Executive Officer